Step by step: The benefits of stage-based R&D licensing contracts

We examine how a licensor can optimally design licensing contracts for multi-phase R&D projects when he does not know the licensee’s project valuation, leading to adverse selection, and cannot enforce the licensee’s effort level, resulting in moral hazard. We focus on the effect of the phased na...

Full description

Saved in:
Bibliographic Details
Main Authors: Crama, Pascale, DE REYCK, Bert, Degraeve, Zeger
Format: text
Language:English
Published: Institutional Knowledge at Singapore Management University 2013
Subjects:
Online Access:https://ink.library.smu.edu.sg/lkcsb_research/3228
https://ink.library.smu.edu.sg/context/lkcsb_research/article/4227/viewcontent/Crama2013EJORStepbyStep_AFV.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Singapore Management University
Language: English
id sg-smu-ink.lkcsb_research-4227
record_format dspace
spelling sg-smu-ink.lkcsb_research-42272021-08-30T04:25:57Z Step by step: The benefits of stage-based R&D licensing contracts Crama, Pascale DE REYCK, Bert Degraeve, Zeger We examine how a licensor can optimally design licensing contracts for multi-phase R&D projects when he does not know the licensee’s project valuation, leading to adverse selection, and cannot enforce the licensee’s effort level, resulting in moral hazard. We focus on the effect of the phased nature typical of such projects, and compare single-phase and multi-phase contracts. We determine the optimal values for the upfront payment, milestone payments and royalties, and the optimal timing for outlicensing. Including multiple milestones and accompanying payments can be an effective way of discriminating between licensees holding different valuations, without having to manipulate the royalty rate, which induces licensees to invest less, resulting in lower project values and socially suboptimal solutions. Interestingly, we also find that multiple milestone payments are beneficial even when the licensor is risk-averse, contrary to standard contract theory results, which recommend that only an upfront payment should be used. In terms of licensing timing, we show that the optimal time depends on the licensor’s risk aversion, the characteristics of the licensee and the project value. 2013-02-01T08:00:00Z text application/pdf https://ink.library.smu.edu.sg/lkcsb_research/3228 info:doi/10.1016/j.ejor.2012.09.014 https://ink.library.smu.edu.sg/context/lkcsb_research/article/4227/viewcontent/Crama2013EJORStepbyStep_AFV.pdf http://creativecommons.org/licenses/by-nc-nd/4.0/ Research Collection Lee Kong Chian School Of Business eng Institutional Knowledge at Singapore Management University Research and development Innovation Contract design Asymmetric information Industries Pharmaceutical Operations and Supply Chain Management Technology and Innovation
institution Singapore Management University
building SMU Libraries
continent Asia
country Singapore
Singapore
content_provider SMU Libraries
collection InK@SMU
language English
topic Research and development
Innovation
Contract design
Asymmetric information
Industries
Pharmaceutical
Operations and Supply Chain Management
Technology and Innovation
spellingShingle Research and development
Innovation
Contract design
Asymmetric information
Industries
Pharmaceutical
Operations and Supply Chain Management
Technology and Innovation
Crama, Pascale
DE REYCK, Bert
Degraeve, Zeger
Step by step: The benefits of stage-based R&D licensing contracts
description We examine how a licensor can optimally design licensing contracts for multi-phase R&D projects when he does not know the licensee’s project valuation, leading to adverse selection, and cannot enforce the licensee’s effort level, resulting in moral hazard. We focus on the effect of the phased nature typical of such projects, and compare single-phase and multi-phase contracts. We determine the optimal values for the upfront payment, milestone payments and royalties, and the optimal timing for outlicensing. Including multiple milestones and accompanying payments can be an effective way of discriminating between licensees holding different valuations, without having to manipulate the royalty rate, which induces licensees to invest less, resulting in lower project values and socially suboptimal solutions. Interestingly, we also find that multiple milestone payments are beneficial even when the licensor is risk-averse, contrary to standard contract theory results, which recommend that only an upfront payment should be used. In terms of licensing timing, we show that the optimal time depends on the licensor’s risk aversion, the characteristics of the licensee and the project value.
format text
author Crama, Pascale
DE REYCK, Bert
Degraeve, Zeger
author_facet Crama, Pascale
DE REYCK, Bert
Degraeve, Zeger
author_sort Crama, Pascale
title Step by step: The benefits of stage-based R&D licensing contracts
title_short Step by step: The benefits of stage-based R&D licensing contracts
title_full Step by step: The benefits of stage-based R&D licensing contracts
title_fullStr Step by step: The benefits of stage-based R&D licensing contracts
title_full_unstemmed Step by step: The benefits of stage-based R&D licensing contracts
title_sort step by step: the benefits of stage-based r&d licensing contracts
publisher Institutional Knowledge at Singapore Management University
publishDate 2013
url https://ink.library.smu.edu.sg/lkcsb_research/3228
https://ink.library.smu.edu.sg/context/lkcsb_research/article/4227/viewcontent/Crama2013EJORStepbyStep_AFV.pdf
_version_ 1770571329512144896